Who
Edwin Kania
Director
Company insider
Files Form 4 as: Director, TransMedics Group; 10% owner, Moderna; 10% owner, Syros Pharmaceuticals; Director, Cartesian Therapeutics; 10% owner, Eleven Biotherapeutics; Director, Acceleron Pharma; 10% owner, BG Medicine; 10% owner, Receptos.
In numbers
- Trades disclosed
- 163
- Buys
- 7
- Sells
- 18
- Bought
- $10.4M
- Sold
- $65.9M
- Companies
- 11
- Companies where not an officer
- 11
- First trade
- 21 Jul 2006
- Last trade
- 20 May 2026
- Last filed
- 22 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 May 2026filed 22 May 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —2,922 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —2,922 at $0.00 | filing |
| 22 May 2025filed 23 May 2025 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —2,134 at $0.00 | filing |
| 23 May 2024filed 28 May 2024 | TMDX TransMedics Groupoption or derivative · Medical Devices | SEC FORM 4 Code A | —1,154 at $0.00 | filing |
| 23 May 2024filed 28 May 2024 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —732 at $0.00 | filing |
| 25 May 2023filed 30 May 2023 | TMDX TransMedics Groupoption or derivative · Medical Devices | SEC FORM 4 Code A | —1,916 at $0.00 | filing |
| 25 May 2023filed 30 May 2023 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —1,193 at $0.00 | filing |
| 28 Feb 2023filed 2 Mar 2023 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code J | $11.6M145,601 at $79.76 | filing |
| 28 Feb 2023filed 2 Mar 2023 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code J | $7.7M96,876 at $79.76 | filing |
| 1 Jun 2022filed 6 Jun 2022 | TMDX TransMedics Groupoption or derivative · Medical Devices | SEC FORM 4 Code A | —13,500 at $0.00 | filing |
| 29 Nov 2021filed 30 Nov 2021 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Bought | $574K25,938 at $22.14 | filing |
| 29 Nov 2021filed 30 Nov 2021 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Bought | $1.7M74,062 at $22.71 | filing |
| 19 Nov 2021filed 22 Nov 2021 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code J | —3,873 at $0.00 | filing |
| 19 Nov 2021filed 22 Nov 2021 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code J | —48,966 at $0.00 | filing |
| 17 Nov 2021filed 22 Nov 2021 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code J | —779,571 at $0.00 | filing |
| 17 Nov 2021filed 22 Nov 2021 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code J | —25,234 at $0.00 | filing |
| 17 Nov 2021filed 22 Nov 2021 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code G | —11,000 at $0.00 | filing |
| 17 Nov 2021filed 22 Nov 2021 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code J | —46,142 at $0.00 | filing |
| 27 May 2021filed 1 Jun 2021 | TMDX TransMedics Groupoption or derivative · Medical Devices | SEC FORM 4 Code A | —13,500 at $0.00 | filing |
| 14 Jan 2020filed 14 Jan 2020 | MRNA ModernaBiotechnology | SEC FORM 4 Sold | $2.4M117,625 at $20.01 | filing |
News
Moderna (NASDAQ:MRNA) Shares Up 1.2% – Here's WhyMRNA · dailypolitical.com · 13 Oct 2026TransMedics Group (NASDAQ:TMDX) and Cerus (NASDAQ:CERS) Head-To-Head ContrastTMDX · themarketsdaily.com · 13 Oct 2026TransMedics Group (NASDAQ:TMDX) Research Coverage Started at BarclaysTMDX · themarketsdaily.com · 10 Oct 2026Moderna (MRNA) Was Removed From the Nasdaq-100 and Is Going Back In. What Changed?MRNA · insidermonkey.com · 9 Oct 2026
0 headlines in the last 90 days name Edwin Kania; 4 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.